Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smyth

Showing results (271-280 of 294) with videos related to

Pageof 30
Sort By:
Cancer Research|October 5, 2001
BARX2 induces cadherin 6 expression and is a functional suppressor of ovarian cancer progressionG C Sellar, L Li, K P Watt, et al.
British Journal of Cancer|July 1, 1994
Can long-term survival be improved in patients with small-cell lung cancer (SCLC) and good performance status? Medical Research Council Lung Cancer Working PartyN M Bleehen, D J Girling, A Gregor, et al.
Growth Factors (Chur, Switzerland)|June 1, 2000
Stoichiometry, kinetic and binding analysis of the interaction between epidermal growth factor (EGF) and the extracellular domain of the EGF receptorT Domagala, N Konstantopoulos, F Smyth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1992
Phase II trials of fosquidone (GR63178A) in carcinoma of the breast, head and neck, ovary and melanomaS B Kaye, J Wanders, M Clavel, et al.
British Journal of Cancer|October 1, 1991
A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working PartyN M Bleehen, D J Girling, A Gregor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Potentiation of cisplatin by alpha-interferon in advanced non-small cell lung cancer (NSCLC): a phase II studyA Bowman, R J Fergusson, S G Allan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Phase II study of E7070 in patients with metastatic melanomaJ F Smyth, S Aamdal, A Awada, et al.
British Journal of Cancer|August 1, 1994
Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group StudyC N Sternberg, W W ten Bokkel Huinink, J F Smyth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parametersMichael D Oberst, Michael D Johnson, Robert B Dickson, et al.
Cancer Research|May 22, 2009
WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3Charlie Gourley, Adam J W Paige, Karen J Taylor, et al.
Pageof 30

Showing results (271-280 of 294) with videos related to

Sort By:
Pageof 30
Cancer Research|October 5, 2001
BARX2 induces cadherin 6 expression and is a functional suppressor of ovarian cancer progressionG C Sellar, L Li, K P Watt, et al.
British Journal of Cancer|July 1, 1994
Can long-term survival be improved in patients with small-cell lung cancer (SCLC) and good performance status? Medical Research Council Lung Cancer Working PartyN M Bleehen, D J Girling, A Gregor, et al.
Growth Factors (Chur, Switzerland)|June 1, 2000
Stoichiometry, kinetic and binding analysis of the interaction between epidermal growth factor (EGF) and the extracellular domain of the EGF receptorT Domagala, N Konstantopoulos, F Smyth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1992
Phase II trials of fosquidone (GR63178A) in carcinoma of the breast, head and neck, ovary and melanomaS B Kaye, J Wanders, M Clavel, et al.
British Journal of Cancer|October 1, 1991
A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working PartyN M Bleehen, D J Girling, A Gregor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Potentiation of cisplatin by alpha-interferon in advanced non-small cell lung cancer (NSCLC): a phase II studyA Bowman, R J Fergusson, S G Allan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Phase II study of E7070 in patients with metastatic melanomaJ F Smyth, S Aamdal, A Awada, et al.
British Journal of Cancer|August 1, 1994
Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group StudyC N Sternberg, W W ten Bokkel Huinink, J F Smyth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parametersMichael D Oberst, Michael D Johnson, Robert B Dickson, et al.
Cancer Research|May 22, 2009
WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3Charlie Gourley, Adam J W Paige, Karen J Taylor, et al.
Pageof 30